Oracle and AstraZeneca enter agreement to advance AI-enabled healthcare innovation: Austin, Texas Thursday, October 22, 2026, 11:00 Hrs [IST] Oracle, a global technology giant off ...
AstraZeneca and Amgen present positive results from phase III CROSSING trial of Tezspire in patients with symptomatic and uncontrolled eosinophilic esophagitis at United European ...
Western UP and Delhi pharmacy colleges to host state celebration of World Pharmacist’s Day 2026: Peethaambaran Kunnathoor, Chennai Thursday, October 22, 2026, 08:00 Hrs [IST] In ...
PSK proposes 'Locum Pharmacist Service Bank' app to curb illegal dispensing & boost shift employment: Peethaambaran Kunnathoor, Chennai Thursday, October 22, 2026, 08:00 Hrs [IST] ...
Indian healthcare providers have expressed support for the Government of India’s (GOI) rule mandating the display of prices for patient services, highlighting the importance of transparency, ...
India’s medical device sector accelerates innovation from validation to scale: Nandita Vijayasimha, Bengaluru Thursday, October 22, 2026, 08:00 Hrs [IST] India’s healthcare se ...
IDMA, US FDA explore stronger regulatory cooperation on pharma quality and compliance: Shardul Nautiyal, Mumbai Thursday, October 22, 2026, 08:00 Hrs [IST] The Indian Drug Manufac ...
IPA-CPD requests CDSCO to conduct review of all FDCs containing Pregabalin: Gireesh Babu, New Delhi Thursday, October 22, 2026, 08:00 Hrs [IST] The Community Pharmacy Division of ...
Takeda announces first and only UC treat-to-target trial shows treating to disease clearance vs. symptomatic remission with Entyvio prolongs time to first disease-related complica ...
The Central Drugs Standard Control Organization (CDSCO), under the Drug Controller General of India (DCGI), has granted Marketing Authorization to Qfitlia (Fitusiran), the first antithrombin-lowering ...
Motorica launches local production of its own bionic prostheses in India: Our Bureau, Bengaluru Wednesday, October 21, 2026, 15:50 Hrs [IST] Motorica Group, a leading Russian MedT ...
Clene seeks US FDA approval for CNM-Au8 for the treatment of amyotrophic lateral sclerosis: Salt Lake City Wednesday, October 21, 2026, 17:00 Hrs [IST] Clene Inc., a clinical-stag ...